TherapeuticsMD, Inc.
TherapeuticsMD, Inc. (TXMD) Stock Overview
Explore TherapeuticsMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
26.4M
P/E Ratio
87.38
EPS (TTM)
$0.01
ROE
0.01%
TXMD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of TherapeuticsMD, Inc. (TXMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.52, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.75.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 87.38 and a market capitalization of 26.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.